Large-scale testing (Phase 3)Study completedNCT00147316
What this trial is testing
Japan Alteplase Clinical Trial (J-ACT): Efficacy and Safety Study of Tissue Plasminogen Activator (Alteplase) for Ischemic Stroke
Who this might be right for
Cerebral InfarctionBrain Ischemia
Tanabe Pharma Corporation 103